Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-05

Clinical Trial Update: Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents [NA]

View source ↗

Summary

A terminated clinical trial update comparing insulin glargine plus insulin glulisine (Apidra) to NPH insulin plus insulin glulisine in recently diagnosed childr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Insulin glulisine (Apidra) (insulin glulisine)
  • NPH insulin (insulin isophane)

Snippet

Sponsor: Rabin Medical Center | Conditions: Diabetes Type 1 | NA | Status: TERMINATED